Study to Evaluate Efficacy and Safety of Treatment with CNTO 136 in Subjects with Active Lupus Nephritis

Update Il y a 4 ans
Reference: EUCTR2010-020968-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective is to evaluate the efficacy and safety of CNTO 136 administered intravenously (IV) in subjects with active, International Society of Nephrology (ISN)/Renal Pathology Society (RPS) Class III and IV lupus nephritis (LN).


Inclusion criteria

  • Active lupus nephritis